Asymptomatic Aortic Stenosis: A Complex Decision

Asymptomatic severe aortic stenosis continues to pose a significant challenge when it comes to clinical decision-making, often due to the difficulty in identifying symptoms. When this condition is symptomatic or oligosymptomatic, it is associated with increased rates of hospitalization and mortality.

While current guidelines recommend valve replacement in cases of impaired ventricular function, available reports are not definitive regarding its implementation.

Researchers conducted a meta-analysis that included four randomized studies (EARLY TAVR, EVoLVeD, AVATAR, and RECOVERY), with a total of 1427 patients. Of these, 719 underwent early aortic valve replacement through surgical or transcatheter aortic valve replacement (SAVR or TAVR), while the rest underwent clinical follow-up (CF) alone.

Read also: 1-Year Outcomes of US TAVR Registry with 5th Generation Balloon Expandable Valves.

With an average follow-up of four years, TAVR demonstrated a significant reduction in the rates of hospitalization due to cardiovascular causes or heart failure (combined rate: 14.6% vs. 31.9%; hazard ratio [HR]: 0.40; 95% confidence interval [CI]: 0.30–0.53; I² = 4%; p < 0.01) and in the incidence of stroke (combined rate: 4.5% vs. 7.2%; HR: 0.62; 95% CI: 0.40–0.97; I² = 0%; p = 0.03). However, there were no significant differences in all-cause mortality (combined rate: 9.7% vs. 13.7%; HR: 0.68; 95% CI: 0.40–1.17; I² = 61%; p = 0.17) or cardiovascular mortality (combined rate: 5.1% vs. 8.3%; HR: 0.67; 95% CI: 0.35–1.29; I² = 50%; p = 0.23). It is worth noting that the studies analyzed were highly heterogeneous.

Conclusion

In this meta-analysis of four randomized studies, early aortic valve replacement was associated with a significant reduction in hospitalization rates due to cardiovascular causes or heart failure, as well as in the incidence of stroke. However, there were no differences in all-cause mortality or cardiovascular mortality compared to clinical follow-up.

Original Title: Aortic Valve Replacement vs Clinical Surveillance in Asymptomatic Severe Aortic Stenosis: A Systematic Review and Meta-Analysis. 

Reference: Philippe Généreux, et al. JACC article in press.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

Dr. Carlos Fava
Dr. Carlos Fava
Member of the Editorial Board of solaci.org

More articles by this author

One-Year Results of ENCIRCLE: Percutaneous Mitral Valve Replacement in Patients Ineligible for Surgery or TEER

Symptomatic mitral regurgitation (MR) in patients who are not candidates for surgery or transcatheter edge-to-edge repair (TEER) remains a highly complex clinical scenario associated...

Can Coronary CT Angiography Replace Invasive Coronary Angiography in Pre-TAVI Coronary Assessment?

Coronary artery disease coexists in approximately half of patients undergoing transcatheter aortic valve implantation, making coronary assessment prior to the procedure essential. Invasive coronary...

Valve-in-Valve in Small Surgical Aortic Bioprostheses: Balloon-Expandable or Self-Expanding? Three-Year Results from the LYTEN Trial

Dysfunction of small surgical aortic bioprostheses represents a challenging scenario for transcatheter aortic valve replacement in the valve-in-valve setting, due to the higher incidence...

Can TAVI Be Safely Performed in Patients With Bicuspid Aortic Valve?

Bicuspid aortic valve (BAV) represents an anatomical challenge for transcatheter aortic valve replacement (TAVR) due to the frequent presence of elliptical annuli, fibroc calcific...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

OCT- and IVUS-Guided Coronary Angioplasty in Acute Coronary Syndrome: Long-Term Clinical Outcomes

Percutaneous coronary angioplasty (PCI) in patients with acute coronary syndrome (ACS) has reduced mortality in the acute phase. However, recurrent ACS and target vessel...

One-Year Results of ENCIRCLE: Percutaneous Mitral Valve Replacement in Patients Ineligible for Surgery or TEER

Symptomatic mitral regurgitation (MR) in patients who are not candidates for surgery or transcatheter edge-to-edge repair (TEER) remains a highly complex clinical scenario associated...

Can Coronary CT Angiography Replace Invasive Coronary Angiography in Pre-TAVI Coronary Assessment?

Coronary artery disease coexists in approximately half of patients undergoing transcatheter aortic valve implantation, making coronary assessment prior to the procedure essential. Invasive coronary...